This paper provided evidence for the presence of three types of self-renewing GBM cells, in which the Sox2+/CD133- type I cell represents the glioma stem cell, which may further differentiate to generate Sox2+/CD133+ type II and Sox2(+)/CD133- type III cells, which may be considered early and late progenitors, respectively. The gene discussed is SOX2; the disease is glioma.